A model of poly IC-driven exacerbations of smoke-induced pulmonary inflammation – does it meet researchers needs?

R. U. Schaefer, B. Jung (Biberach/Riss, Germany)

Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Session: Mechanisms of infection: what's new?
Session type: E-Communication Session
Number: 4773
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. U. Schaefer, B. Jung (Biberach/Riss, Germany). A model of poly IC-driven exacerbations of smoke-induced pulmonary inflammation – does it meet researchers needs?. Eur Respir J 2009; 34: Suppl. 53, 4773

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Targeting the IL-1β – IL-17A inflammatory axis for the treatment of viral-induced exacerbations of COPD
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012

Role of IL-1α and IL-1β in cigarette smoke-induced pulmonary inflammation and COPD
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011


Role of IL-1? and the Nlrp3/caspase-1/IL-1? axis in cigarette smoke-induced pulmonary inflammation and COPD
Source: Eur Respir J 2011; 38: 1019-1028
Year: 2011



Chronic non-asthmatic cough – Are we nearer to define the airway pathology?
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010


IL-23 is essential to the development of elastase-induced pulmonary inflammation and emphysema
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016

Beyond corticosteroids: future prospects in the management of inflammation in COPD
Source: Eur Respir Rev 2011; 20: 175-182
Year: 2011



Halotherapy – A possible method to enhance airway treatment on patients with obstructive pathology
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012

Cigarette smoke induced pulmonary emphysema is attenuated in CCR6 deficient mice
Source: Annual Congress 2006 - Cell biology of asthma and COPD
Year: 2006


Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013

Evasion of COPD in smokers: at what price?
Source: Eur Respir J 2012; 39: 1298-1303
Year: 2012



Modulation of airway inflammation to prevent exacerbations of COPD
Source: Eur Respir Rev 2005; 14: 78-82
Year: 2005



Cigarette smoke-induced pulmonary inflammation, but not airway wall remodeling, is attenuated in CCR5 deficient mice
Source: Annual Congress 2007 - The best of airway epithelial cells
Year: 2007



Expression of MIC-A in bronchial epithelium associates with cigarette smoking: a sign of induced autoimmune mechanisms?
Source: Annual Congress 2005 - Lung structure: current concepts
Year: 2005


Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives
Source: Eur Respir Rev 2015; 24: 594-601
Year: 2015



Tiotropium effects on airway inflammatory events in the cat as an animal model for acute cigarette smoke-induced lung inflammation
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014

Differences in the polarization of the inflammatory response of patients with chronic obstructive pulmonary disease (COPD) secondary to smoking and to biomass smoke exposure
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013


Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015

IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021


LSC 2010 Abstract: Synthetic dsRNA exacerbates pulmonary inflammation in acute and sub-chronic in vivo models of COPD
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010

Why is it important to consider (sub)phenotypes of asthma and COPD?
Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not?
Year: 2005